Query psy4355
Match_columns 71
No_of_seqs 228 out of 1410
Neff 9.2
Searched_HMMs 29240
Date Fri Aug 16 23:26:06 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy4355.a3m -d /work/01045/syshi/HHdatabase/pdb70.hhm -o /work/01045/syshi/hhsearch_pdb/4355hhsearch_pdb -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 2lnl_A C-X-C chemokine recepto 99.5 4.7E-14 1.6E-18 84.4 8.5 59 10-69 20-78 (296)
2 2rh1_A Beta-2-adrenergic recep 99.4 4.6E-13 1.6E-17 85.3 7.5 61 8-68 47-107 (500)
3 2ks9_A Substance-P receptor; w 99.4 9.6E-13 3.3E-17 80.3 8.3 60 9-68 40-99 (364)
4 3rze_A Histamine H1 receptor, 99.4 6.3E-13 2.2E-17 82.8 7.3 62 7-68 14-75 (452)
5 3v2y_A Sphingosine 1-phosphate 99.4 8.3E-13 2.8E-17 84.7 7.8 54 8-61 70-123 (520)
6 3uon_A Human M2 muscarinic ace 99.4 1.1E-12 3.6E-17 82.1 8.0 61 8-68 30-90 (467)
7 4dkl_A MU-type opioid receptor 99.4 2.2E-12 7.7E-17 80.4 9.1 60 8-68 24-83 (464)
8 1u19_A Rhodopsin; G protein-co 99.4 1.9E-12 6.4E-17 78.3 7.7 61 8-68 45-105 (349)
9 3pbl_A D(3) dopamine receptor, 99.4 2.7E-12 9.2E-17 80.6 8.6 62 6-67 43-105 (481)
10 4amj_A Beta-1 adrenergic recep 99.4 7E-13 2.4E-17 79.0 5.5 61 8-68 18-78 (315)
11 4grv_A Neurotensin receptor ty 99.4 8.8E-13 3E-17 84.5 5.8 56 9-64 40-98 (510)
12 3vw7_A Proteinase-activated re 99.4 3.6E-12 1.2E-16 80.0 7.8 60 8-68 27-87 (484)
13 3sn6_R Lysozyme, beta-2 adrene 99.3 3.2E-12 1.1E-16 81.6 7.0 61 8-68 189-249 (514)
14 3odu_A C-X-C chemokine recepto 99.3 3.7E-12 1.3E-16 80.3 6.6 58 8-66 55-112 (502)
15 4eiy_A Adenosine receptor A2A/ 99.3 7.7E-12 2.6E-16 77.8 7.6 55 8-62 38-92 (447)
16 3eml_A Human adenosine A2A rec 99.3 6.1E-12 2.1E-16 78.9 6.9 56 8-63 28-83 (488)
17 4ea3_A Fusion protein of nocic 99.3 7.7E-12 2.6E-16 78.4 7.3 60 8-68 132-191 (434)
18 2z73_A Rhodopsin; visual pigme 99.3 1.3E-11 4.5E-16 77.3 7.3 60 9-68 42-102 (448)
19 2lot_A Apelin receptor; membra 95.7 0.00066 2.3E-08 32.9 -1.6 24 9-32 36-59 (64)
No 1
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens}
Probab=99.54 E-value=4.7e-14 Score=84.39 Aligned_cols=59 Identities=31% Similarity=0.377 Sum_probs=48.9
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcccCC
Q psy4355 10 NYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAKCFS 69 (71)
Q Consensus 10 ~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~~~~ 69 (71)
+..++|++||.++++++.++|++|+++|+|+.|||++|++.+ ...|....+...++.+|
T Consensus 20 ii~i~gv~gN~lvi~vi~~~~~lrt~~n~~i~nLAvaDll~~-l~~p~~~~~~~~~~~~~ 78 (296)
T 2lnl_A 20 LVFLLSLLGNSLVMLVILYSRVGRSVTDVYLLNLALADLLFA-LTLPIWAASKVNGWIFG 78 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTCCSTTHHHHHHHHHHHHHHH-HHHHHHHHHHHSSSCCS
T ss_pred HHHHHHHHHHHHHHHHHHHccCCCChHHHHHHHHHHHHHHHH-HhhhHHHhhccCCCccc
Confidence 445567899999999999999999999999999999999985 46787777766654444
No 2
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A*
Probab=99.43 E-value=4.6e-13 Score=85.35 Aligned_cols=61 Identities=39% Similarity=0.472 Sum_probs=53.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcccC
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAKCF 68 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~~~ 68 (71)
+.+.+++|++||+++++++.+++++|+++|+|+.|||++|++.++..+|..+.+...+.|.
T Consensus 47 ~~~i~~~gi~gN~lvi~~i~~~~~l~~~~~~~l~nLAiaDll~~~~~~p~~~~~~~~~~w~ 107 (500)
T 2rh1_A 47 MSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWT 107 (500)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCGGGCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHTSCC
T ss_pred HHHHHHHHHHHHHHHHHHHhhcCccCcccHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCc
Confidence 3445566799999999999999999999999999999999999999999998888777664
No 3
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A
Probab=99.42 E-value=9.6e-13 Score=80.27 Aligned_cols=60 Identities=25% Similarity=0.362 Sum_probs=52.5
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcccC
Q psy4355 9 PNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAKCF 68 (71)
Q Consensus 9 ~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~~~ 68 (71)
.+.+++|++||.++++++.++|++|+++|+++.|||++|++.+....|..+.....+.|.
T Consensus 40 ~~i~~~gi~gN~lvi~vi~~~~~l~~~~~~~l~~LaiaDll~~~~~~p~~~~~~~~~~~~ 99 (364)
T 2ks9_A 40 TVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWY 99 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCTTCCCHHHHHHHHHHHHHHHHHHTHHHHHHHHHHHTSCS
T ss_pred HHHHHHHHHHHHHHHHHHHhcccccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcc
Confidence 345566799999999999999999999999999999999999888999988877777664
No 4
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens}
Probab=99.42 E-value=6.3e-13 Score=82.79 Aligned_cols=62 Identities=37% Similarity=0.477 Sum_probs=55.1
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcccC
Q psy4355 7 DIPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAKCF 68 (71)
Q Consensus 7 ~~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~~~ 68 (71)
++.+.+++|++||+++++++.+++++|+++|+|+.|||++|++.++..+|..+.+...+.|.
T Consensus 14 ~~~~~~~~gi~gN~~vi~~~~~~~~~~~~~~~~l~~La~~Dll~~~~~~p~~~~~~~~~~~~ 75 (452)
T 3rze_A 14 VLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWS 75 (452)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCSTTCCGGGHHHHHHHHHHHHHHHTHHHHHHHHHHSSSCS
T ss_pred HHHHHHHHHHHHHHHHHHHHHhccccCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcc
Confidence 44556677899999999999999999999999999999999999999999999888877764
No 5
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A*
Probab=99.41 E-value=8.3e-13 Score=84.67 Aligned_cols=54 Identities=20% Similarity=0.244 Sum_probs=48.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHH
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVY 61 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~ 61 (71)
+.+.+++|++||+++++++.+++++|+++|+|+.|||++|+++++...|..+..
T Consensus 70 ~~~i~~~g~~gN~lvi~vi~~~~~lr~~~~~~l~nLA~aDll~~~~~~p~~~~~ 123 (520)
T 3v2y_A 70 FILICCFIILENIFVLLTIWKTKKFHRPMYYFIGNLALSDLLAGVAYTANLLLS 123 (520)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCSTTCSHHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHHHHHHHHhCccccChHHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 344566679999999999999999999999999999999999999888888766
No 6
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A*
Probab=99.41 E-value=1.1e-12 Score=82.06 Aligned_cols=61 Identities=30% Similarity=0.438 Sum_probs=53.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcccC
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAKCF 68 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~~~ 68 (71)
..+.+++|++||+++++++.+++++|+++|+|+.|||++|++.++...|..+.....+.|.
T Consensus 30 ~~~~~~~g~~gN~lvi~~~~~~~~~~~~~~~~l~~La~aDll~~~~~~p~~~~~~~~~~~~ 90 (467)
T 3uon_A 30 AGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWP 90 (467)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCGGGCSHHHHHHHHHHHHHHHHHHTHHHHHHHHHHSSSCC
T ss_pred HHHHHHHHHHHHHHheeeeeecCccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 3345566799999999999999999999999999999999999999999999888877764
No 7
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A*
Probab=99.40 E-value=2.2e-12 Score=80.40 Aligned_cols=60 Identities=20% Similarity=0.232 Sum_probs=51.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcccC
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAKCF 68 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~~~ 68 (71)
..+.+++|++||+++++++.+++++|+++|+|+.|||++|++.++. +|..+.....+.|.
T Consensus 24 ~~~~~~~gi~gN~lvi~~~~~~~~~~~~~~~~l~~La~~Dll~~~~-~p~~~~~~~~~~~~ 83 (464)
T 4dkl_A 24 YSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATST-LPFQSVNYLMGTWP 83 (464)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCSTTCSHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHSSCC
T ss_pred HHHHHHHHHHHHHHeehhhhhccccCCHHHHHHHHHHHHHHHHHHH-HHHHHHHHHhCCcc
Confidence 3445666799999999999999999999999999999999998665 99988888777764
No 8
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ...
Probab=99.38 E-value=1.9e-12 Score=78.29 Aligned_cols=61 Identities=20% Similarity=0.171 Sum_probs=52.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcccC
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAKCF 68 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~~~ 68 (71)
..+.+++|++||.+++.++.+++++|+++|+++.|||++|++.+....|..+.....+.|.
T Consensus 45 ~~~i~~~gi~gN~lvi~~i~~~~~~~~~~~~ll~~Lai~Dll~~~~~~~~~~~~~~~~~~~ 105 (349)
T 1u19_A 45 MFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFV 105 (349)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHTSCT
T ss_pred HHHHHHHHHHhHHheEeehhhhhhhcCchhHHHHHHHHHHHHHHHhcchHHHHHHhcCeee
Confidence 3445667799999999999999999999999999999999999888899988777766663
No 9
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens}
Probab=99.38 E-value=2.7e-12 Score=80.56 Aligned_cols=62 Identities=42% Similarity=0.508 Sum_probs=53.4
Q ss_pred chHHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhh-ccc
Q psy4355 6 PDIPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELN-AKC 67 (71)
Q Consensus 6 ~~~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~-~~~ 67 (71)
..+.+.+++|++||+++++++.+++++|+++|+|+.|||++|++.++..+|..+..... +.|
T Consensus 43 ~~~~~~~~~g~~gN~lvi~~~~~~~~~~~~~~~~l~~La~aDll~~~~~~p~~~~~~~~~~~~ 105 (481)
T 3pbl_A 43 LSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVW 105 (481)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHCSTTCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHTTSCC
T ss_pred HHHHHHHHHHHHHHHHHhHHhhhccccCCchHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 34556677789999999999999999999999999999999999999999998877665 445
No 10
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A*
Probab=99.38 E-value=7e-13 Score=78.98 Aligned_cols=61 Identities=39% Similarity=0.496 Sum_probs=53.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcccC
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAKCF 68 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~~~ 68 (71)
..+.+++|++||.+++.++.+++++|+++|+++.|||++|++.+....|..+.....+.|.
T Consensus 18 ~~~~~~~gi~gN~lvi~~i~~~~~~~~~~~~ll~~LaiaDll~~~~~~p~~~~~~~~~~~~ 78 (315)
T 4amj_A 18 MALVVLLIVAGNVLVIAAIGSTQRLQTLTNLFITSLACADLVVGLLVVPFGATLVVRGTWL 78 (315)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCGGGCCHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHSSCC
T ss_pred HHHHHHHHHHHHHHHhHHhhhchhhcchHHHHHHHHHHHHHHHHHHhccHHHHHHhcCCee
Confidence 3445667799999999999999999999999999999999999888999988887777764
No 11
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus}
Probab=99.37 E-value=8.8e-13 Score=84.47 Aligned_cols=56 Identities=25% Similarity=0.265 Sum_probs=45.7
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcC---cccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhh
Q psy4355 9 PNYKLYFNYRNVFVIAAILLEKN---LQSVANYLIVSLAVADLMVACLVMPLGAVYELN 64 (71)
Q Consensus 9 ~~~~l~~~~gN~~vi~~~~~~~~---l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~ 64 (71)
.+.+++|++||+++++++.++|+ +|+++|+|+.|||++|++++++.+|+.+.+...
T Consensus 40 ~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~ 98 (510)
T 4grv_A 40 LALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIW 98 (510)
T ss_dssp HHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34456678999999999887764 458999999999999999999999999887653
No 12
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens}
Probab=99.35 E-value=3.6e-12 Score=80.04 Aligned_cols=60 Identities=17% Similarity=0.258 Sum_probs=47.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHh-hcccC
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYEL-NAKCF 68 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~-~~~~~ 68 (71)
+.+.+++|++||+++++++.+++++|+++|+|+.|||++|++.++. .|....... .+.|.
T Consensus 27 ~~~i~~~~i~gN~lvi~~~~~~~~l~~~~~~~l~~La~aDll~~~~-~~~~~~~~~~~~~~~ 87 (484)
T 3vw7_A 27 YTGVFVVSLPLNIMAIVVFILKMKVKKPAVVYMLHLATADVLFVSV-LPFKISYYFSGSDWQ 87 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHTT-HHHHHHHHHTTSCCC
T ss_pred HHHHHHHHHHHHHHHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH-HHHHHHHHHhcCCcc
Confidence 3445666799999999999999999999999999999999999654 565555444 43553
No 13
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A*
Probab=99.34 E-value=3.2e-12 Score=81.61 Aligned_cols=61 Identities=39% Similarity=0.495 Sum_probs=53.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcccC
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAKCF 68 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~~~ 68 (71)
..+.+++|++||+++++++.+++++|+++|+++.|||++|++.++..+|..+.....+.|.
T Consensus 189 ~~ii~~~gi~gN~lvi~vi~~~~~lr~~~~~ll~nLAiaDll~~~~~~p~~~~~~~~~~~~ 249 (514)
T 3sn6_R 189 MSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILTKTWT 249 (514)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCGGGCCHHHHHHHHHHHHHHTTTTTHHHHHHHHHHHTSCC
T ss_pred HHHHHHHHHHhHHHhhhheecccccccHHHHHHHHHHHHHHHHHHHhCHHHHHHHHcCCee
Confidence 3445667799999999999999999999999999999999999888999998888777664
No 14
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B*
Probab=99.32 E-value=3.7e-12 Score=80.28 Aligned_cols=58 Identities=26% Similarity=0.238 Sum_probs=49.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcc
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAK 66 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~ 66 (71)
+.+.+++|++||+++++++.+++++|+++|+|+.|||++|++. .+.+|..+.....++
T Consensus 55 ~~~i~~~g~~gN~lvi~~~~~~~~l~~~~~~~l~~La~~Dll~-~~~~p~~~~~~~~~~ 112 (502)
T 3odu_A 55 YSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLF-VITLPFWAVDAVANW 112 (502)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTTCCSCCHHHHHHHHHHHHHHHH-HTTHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHHHHHhcccCCCHHHHHHHHHHHHHHHH-HHHHHHHHHHHhcCC
Confidence 3445566799999999999999999999999999999999999 578999888776643
No 15
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A
Probab=99.31 E-value=7.7e-12 Score=77.77 Aligned_cols=55 Identities=36% Similarity=0.484 Sum_probs=48.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHH
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYE 62 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~ 62 (71)
..+.+++|++||+++++++.+++++|+++|+++.|||++|++.++..+|..+...
T Consensus 38 ~~~i~~~gi~gN~~vl~~~~~~~~l~~~~~~~l~~La~~Dll~~~~~~p~~~~~~ 92 (447)
T 4eiy_A 38 ELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITIS 92 (447)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCGGGCSHHHHHHHHHHHHHHHHHHTHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHccccCcHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 3445667799999999999999999999999999999999999899999887644
No 16
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A*
Probab=99.31 E-value=6.1e-12 Score=78.86 Aligned_cols=56 Identities=36% Similarity=0.468 Sum_probs=49.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHh
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYEL 63 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~ 63 (71)
..+.+++|++||+++++++.+++++|+++|+|+.|||++|++.++..+|..+....
T Consensus 28 ~~~i~~~gi~gN~lvi~~~~~~~~~~~~~~~~l~~La~aDll~~~~~~p~~~~~~~ 83 (488)
T 3eml_A 28 ELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITIST 83 (488)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCGGGCSSHHHHHHHHHHHHHHHHHTHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhhhheeeccccCChHHHHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 34456677999999999999999999999999999999999999999998876543
No 17
>4ea3_A Fusion protein of nociceptin receptor and cytochr; PSI-biology GPCR network, structural genomics, GPCR membrane 7TM NOP ORL1 cytochrome B562; HET: 0NN OLB OLA OLC; 3.01A {Homo sapiens}
Probab=99.30 E-value=7.7e-12 Score=78.41 Aligned_cols=60 Identities=23% Similarity=0.197 Sum_probs=51.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHHhHHHHHHHhhcccC
Q psy4355 8 IPNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLVMPLGAVYELNAKCF 68 (71)
Q Consensus 8 ~~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~~p~~~~~~~~~~~~ 68 (71)
..+.+++|++||+++++++.+++++|+++|+++.|||++|++. .+..|..+.....+.|.
T Consensus 132 ~~~i~~~gi~gN~lvi~~i~~~~~l~~~~~~ll~~LAvsDll~-~~~~p~~~~~~~~~~~~ 191 (434)
T 4ea3_A 132 YLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLV-LLTLPFQGTDILLGFWP 191 (434)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCSCCCHHHHHHHHHHHHHHHH-HTTHHHHHHHHHHTSCT
T ss_pred HHHHHHHHHHHHHHeeeeeeecCccCchhHHHHHHHHHHHHHH-HHHhHHHHHHHHhcCCc
Confidence 3445566799999999999999999999999999999999998 67889988887777664
No 18
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A*
Probab=99.28 E-value=1.3e-11 Score=77.34 Aligned_cols=60 Identities=25% Similarity=0.207 Sum_probs=50.8
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCcccHHHHHHHHHHHHHHHHHHHH-hHHHHHHHhhcccC
Q psy4355 9 PNYKLYFNYRNVFVIAAILLEKNLQSVANYLIVSLAVADLMVACLV-MPLGAVYELNAKCF 68 (71)
Q Consensus 9 ~~~~l~~~~gN~~vi~~~~~~~~l~~~~~~~l~nLa~aDll~~~~~-~p~~~~~~~~~~~~ 68 (71)
.+.+++|++||+++++++.++|++|+++|+++.|||++|++.++.. +|..+.....+.|.
T Consensus 42 ~ii~i~gi~gN~lvi~vi~~~~~~~~~~~~ll~~LaiaDll~~~~~~~p~~~~~~~~~~~~ 102 (448)
T 2z73_A 42 GICGIIGCGGNGIVIYLFTKTKSLQTPANMFIINLAFSDFTFSLVNGFPLMTISCFLKKWI 102 (448)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCSTTCSTTHHHHHHHHHHHHHHHHHHSTTHHHHHHHTTSCC
T ss_pred HHHHHHHHhhHHHhhhhhhhccccCCccchHHHHHHHHHHHHHHHHhccHHHHHHhcCCcc
Confidence 3455677999999999999999999999999999999999987764 88888777666663
No 19
>2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A
Probab=95.66 E-value=0.00066 Score=32.92 Aligned_cols=24 Identities=17% Similarity=-0.024 Sum_probs=18.0
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCc
Q psy4355 9 PNYKLYFNYRNVFVIAAILLEKNL 32 (71)
Q Consensus 9 ~~~~l~~~~gN~~vi~~~~~~~~l 32 (71)
.+.+++|++||+++++++.++|.-
T Consensus 36 ~lvFvlGl~GN~lvl~v~~~~~~~ 59 (64)
T 2lot_A 36 MLVFLLGTTGNGLVLWTVFRKKGH 59 (64)
T ss_dssp HHTTTTTTTSSSSHHHHHHHHSSS
T ss_pred HHHHHHHHhhhhhheeeeeEeccc
Confidence 334455689999999999887753
Done!